Clin-alert 2001 : a quick reference to adverse clinical events PDF
Preview Clin-alert 2001 : a quick reference to adverse clinical events
Clin-Alert@2 001 HOW TO ORDER THIS BOOK BY PHONE: 800-233-9936o r 71 7-291- 5609, A M- PM Eastern Time BY FM: 717 -295-4538 BY MAIL: Order Department Technomic Publishing Company, Inc. 851 New Holland Avenue, Box 3535 Lancaster, PA 17604,U .S.A. ev CREDIT CARD: American Express, VISA, Mastercard PERMISSION TO PHOTOCOPY-POLICY STATEMENT Authorization to photocopy items for internalo r personal use, or the internal or personal use of specific clients, is granted by Technomic PublishingC o., Inc. provided that the base fee of US $5.00 per copy, plus US $.25 per page is paid directly to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923, USA. For those organizations that have been granted a photocopy license by CCC, a separate system of payment has been arranged. The fee code for users of the Transactional Reporting Service is 1-58716 /01 $5.00 + $.25. A Quick Reference to Adverse Clinical Events Edited by JOYCE GENERAL4 MS, RPh, FASHP Drug lnbrmation Center Universdy of Kansas J ,ANCASTER-BASEi, Technomic Publishing Company, Inc. 851 New Holland Avenue, Box 3535 Lancaster, Pennsylvania 17604 U.S.A. Copyright O 2001 by Technomic Publishing Company, Inc. All rights reserved No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of the publisher. Printed in the United States of America l 0 9 8 7 6 5 4 3 2 1 Main entry under title: clin-~lert@20 01: A Quick Reference to Adverse Clinical Events A Technomic Publishing Company book Bibliography: p. Includes index p. 243 Library of Congress Catalog Card No. 00-1 12051 ISBN NO. 1-58716-078-1 ........................................... Acknowledgements vii .................................................... Introduction ix .......................................... Alternative Medicines 3 .................................................. Antiinfectives 17 ................................................ Antineoplastics 51 .......................................................... Blood 67 ........................................................ Cardiac 85 ............................................................ CNS 101 ........................................................... EENT 147 ........................................ Gastrointestinal Agents 155 ..................................................... Hormones 167 ................................................. Misceilaneous 187 ............................................ Respiratory Agents 217 ............................................................ Skin 225 ......................................... Drug Interaction Index 243 v vi Contents ................................. FDNManufacturer Alert Index 247 .............................................. First Report Index 249 ............................................. Legal Action Index 251 ........................... Newly Marketed Drugs: 1997-2000 253 ..................................................... Drug Index 255 Acknowledgements Many thanks and appreciation to Stephen Spangler, Bennett Rabiega, Michael B. Brown and the staff at Technomic Publishing Company for their hard work and efforts in making this book possible. Recognition for continuing support to my family Steven, Jessica and Jonathan Whitfield and my parents Silvio and Vilma Generali. vii Keeping current with the safety profiles of drug therapy is essential in optimizing decisions regarding patient health care. However, with the ad- dition of 25 to 30 new drugs to the United States market each year, this task becomes formidable. Although all drugs are tested for safety during premarketing trials, the full scope of the safety profile and drug interactions is not realized until the drug has been on the market for several years and used in a varied population in clinical scenarios that often involve polyphar- macy. Thus, attention to potential side effects and drug interactions remains an important component of effective and rational drug therapy. Changing safety profiles are not limited only to new drugs as new in- formation is also published regarding new adverse reactions andlor drug interactions with older products. In addition, the popularity of alternative medicines and their use with conventional medicines has created a new need for information regarding drug interactions in this area. The Clin-Alert newsletter is designed to collect, summarize and report newly published information regarding significant adverse drug events and drug interactions. In the last three years, the scope of the newsletter has expanded to include information on alternative medicines and herbal ther- apies, and to alert health care professionals regarding F'DA notifications and public health advisories. This book is the second compilation of abstracts published in Clin-Alert and collates the reports presented in Clin-Alert for the last year. The abstracts are arranged by drug class and there are six indices for easy accessibility. This year a new index has been added which highlights adverse drug events with newly marketed agents (1997-2000). Although most of the presented abstracts are summaries of published case reports, several abstracts also review data from drug interaction studies, prospective safety trials, case series or retrospective investigations. When the information is available a Clin-Alert abstract data regarding the sus- pected adverse event, the suspected drug (dose, duration of therapy and
Description:The list of books you might like
